1Nicholson B. E, Frierson H F, Conaway M R, et al. Profiling the evolution of human metastatic bladder cancer[J].Cancer Res,2004,64:7813-7821.
2Nabeshima K, Komada N, Kishi J I, et al. TPA-enhanced invasion of matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant(L-10) of human rectal adenocarcinoma cell line RCM-1[J]. Int J Cancer, 1993, 55:974-981.
3Amar A P, DeArmond S J, Spencer D R, et al. Devrlopment of an vitro extracellular matrix assay for studies of brain tumor cell invasion[J]. J Neuro-Oncol, 1994,20:1-5.
4Gonteroa P, Banisadrb S, Freaa B, et al. Metastasis Markers in Bladder Cancer:A Review of the Literature and Clinical Considerations [J]. European Urology, 2004, 46:296-311.
5Gotanda T, Haraguchi M, Tachiwada T, et al. Molecular basis for the involvement of thymidine phosphorylase in cancer invasion[J]. Int J Mol Med,2006,17(6): 1085-1091.
6Reiter L S, Kruithof E K, Cajot J, et al. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells[J].Int J Cancer, 1993,54 : 444- 450.
7El-Kott A F, Khalil A M, El-Kenawy Ael-M. Immuno- histochemical expressions of uPA and its receptor uPAR and their prognostic significant in urinary bladder carcinoma [J]. Int Urol Nephrol, 2004, 36:417 -423.
